CIK 0000316709 · Large accelerated filer
SCHWAB CHARLES CORP
Sign in to watch- Ticker
- SCHW
- Exchange
- NYSE
- Industry
- Security Brokers, Dealers & Flotation Companies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943025021
- Phone
- 817-859-5000
- Business address
- 3000 SCHWAB WAY, WESTLAKE, TX, 76262
Securities
- SCHW Charles Schwab Corporation (The) Common Stock NYSE
- SCHW-PD The Charles Schwab Corporation Depositary Shares each representing 1/40th interest in a share of 5.95% Non-Cumulative Perpetual Preferred Stock, Series D NYSE
- SCHW-PJ The Charles Schwab Corporation Depositary Shares, Each Representing a 1/40th Interest in a Share of 4.450% Non-Cumulative Perpetual Preferred Stock, Series J NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,957,188
- in 12 filings, $1.6M under 10b5-1 plans
Net −$69,957,188. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Schwab Charles R. −$39.0M Co-Chairman sold <1% of stake
- Bettinger Walter W −$28.2M Co-Chairman sold 29% of stake
- Hathi Neesha −$1.6M MD, Head Wealth Adv, Bnk, Tst sold 74% of stake
- Schwab-Pomerantz Carolyn −$1.0M Director sold <1% of stake
- Beatty Jonathan S −$111K MD, Head of Advisor Services sold 9% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-15 | Woolway Paul V MD, Chief Banking Officer | Sale 10b5-1 | −7,941 | $100.00 | $794K | 29,866.44 |
| 2026-04-15 | Woolway Paul V MD, Chief Banking Officer | Option exercise · Nonqualified Stock Option (right to buy) 10b5-1 | −7,941 | 0 | ||
| 2026-04-14 | Woolway Paul V MD, Chief Banking Officer | Option exercise 10b5-1 | +7,942 | $52.05 | $413K | 25,153 |
| 2026-04-14 | Woolway Paul V MD, Chief Banking Officer | Sale 10b5-1 | −7,942 | $98.00 | $778K | 29,866.44 |
| 2026-04-14 | Woolway Paul V MD, Chief Banking Officer | Option exercise · Nonqualified Stock Option (right to buy) 10b5-1 | −7,942 | 7,941 | ||
| 2026-04-14 | Craig Jonathan M. MD, Head of Retail Investing | Option exercise 10b5-1 | +21,750 | $46.81 | $1.0M | 0 |
| 2026-04-14 | Craig Jonathan M. MD, Head of Retail Investing | Sale 10b5-1 | −21,750 | $99.00 | $2.2M | 0 |
| 2026-04-14 | Craig Jonathan M. MD, Head of Retail Investing | Option exercise · Nonqualified Stock Option (right to buy) 10b5-1 | −21,750 | 65,366 | ||
| 2026-04-14 | Murtagh Nigel J Chief Risk Officer | Option exercise 10b5-1 | +41,297 | $52.05 | $2.1M | 99,269.48 |
| 2026-04-14 | Murtagh Nigel J Chief Risk Officer | Sale 10b5-1 | −41,297 | $99.00 | $4.1M | 57,972.48 |
| 2026-04-14 | Murtagh Nigel J Chief Risk Officer | Option exercise · Nonqualified Stock Option (right to buy) 10b5-1 | −41,297 | 0 | ||
| 2026-04-01 | Brown Marianne Catherine Director | Grant or award · Restricted Stock Units | +434 | 7,823.67 | ||
| 2026-04-01 | Ruffel Charles A. Director | Grant or award · Nonqualified Stock Option (right to buy) | +1,286 | 1,286 | ||
| 2026-04-01 | Ellis Stephen A Director | Grant or award · Restricted Stock Units | +393 | 12,851.98 | ||
| 2026-04-01 | HERRINGER FRANK C Director | Grant or award · Restricted Stock Units | +474 | 151,757.24 | ||
| 2026-03-24 | Ellis Stephen A Director | Option exercise | +1,899 | $28.38 | $54K | 6,660 |
| 2026-03-24 | Ellis Stephen A Director | Option exercise | +7,866 | $28.96 | $228K | 6,660 |
| 2026-03-24 | Ellis Stephen A Director | Option exercise · Nonqualified Stock Option (right to buy) | −1,899 | $1,899.00 | $3.6M | 0 |
| 2026-03-24 | Ellis Stephen A Director | Option exercise · Nonqualified Stock Option (right to buy) | −7,866 | $7,866.00 | $61.9M | 0 |
| 2026-03-03 | Howard Dennis MD, Chief Tech, OPS & Data Off | Sale 10b5-1 | −6,269 | $94.43 | $592K | 14,309 |
Page 8 of 22 · 422 trades